Galectin Therapeutics Inc (GALT)

3.12 +0.06 (+1.96%) USD  |  NASDAQ  |  May 16, 12:40
More

Galectin Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2021. Upgrade now.
Date Value
April 01, 2024 --
November 14, 2023 --
March 31, 2023 --
November 15, 2022 --
Date Value
May 17, 2022 --
April 01, 2022 --
November 16, 2021 --

Revenue Estimates for Next Quarter Range, Past 5 Years

--
Minimum
Nov 16 2021
--
Maximum
Nov 16 2021
--
Average
--
Median
Nov 16 2021

Revenue Estimates for Next Quarter Benchmarks

Madrigal Pharmaceuticals Inc Upgrade
Viking Therapeutics Inc Upgrade
89bio Inc Upgrade
Terns Pharmaceuticals Inc Upgrade
Enanta Pharmaceuticals Inc Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Next Fiscal Year Upgrade